Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.31 - $0.4 $178,188 - $229,920
-574,800 Reduced 65.69%
300,257 $93,000
Q1 2022

May 16, 2022

BUY
$0.37 - $0.69 $323,771 - $603,789
875,057 New
875,057 $340,000
Q1 2019

May 15, 2019

SELL
$1.9 - $3.9 $32,260 - $66,218
-16,979 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$2.04 - $4.17 $150,535 - $307,712
-73,792 Reduced 81.29%
16,979 $37,000
Q3 2018

Nov 14, 2018

BUY
$3.21 - $4.16 $82,278 - $106,629
25,632 Added 39.35%
90,771 $363,000
Q2 2018

Aug 14, 2018

BUY
$3.59 - $14.87 $233,849 - $968,616
65,139 New
65,139 $264,000

Others Institutions Holding CHEK

# of Institutions
1
Shares Held
9.1K
Call Options Held
0
Put Options Held
0

About Check-Cap Ltd


  • Ticker CHEK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 116,412,000
  • Market Cap $72.2M
  • Description
  • Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for d...
More about CHEK
Track This Portfolio

Track Sabby Management, LLC Portfolio

Follow Sabby Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sabby Management, LLC with notifications on news.